Literature DB >> 10398600

HMG-1 as a late mediator of endotoxin lethality in mice.

H Wang1, O Bloom, M Zhang, J M Vishnubhakat, M Ombrellino, J Che, A Frazier, H Yang, S Ivanova, L Borovikova, K R Manogue, E Faist, E Abraham, J Andersson, U Andersson, P E Molina, N N Abumrad, A Sama, K J Tracey.   

Abstract

Endotoxin, a constituent of Gram-negative bacteria, stimulates macrophages to release large quantities of tumor necrosis factor (TNF) and interleukin-1 (IL-1), which can precipitate tissue injury and lethal shock (endotoxemia). Antagonists of TNF and IL-1 have shown limited efficacy in clinical trials, possibly because these cytokines are early mediators in pathogenesis. Here a potential late mediator of lethality is identified and characterized in a mouse model. High mobility group-1 (HMG-1) protein was found to be released by cultured macrophages more than 8 hours after stimulation with endotoxin, TNF, or IL-1. Mice showed increased serum levels of HMG-1 from 8 to 32 hours after endotoxin exposure. Delayed administration of antibodies to HMG-1 attenuated endotoxin lethality in mice, and administration of HMG-1 itself was lethal. Septic patients who succumbed to infection had increased serum HMG-1 levels, suggesting that this protein warrants investigation as a therapeutic target.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10398600     DOI: 10.1126/science.285.5425.248

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  1217 in total

1.  Hemofiltration in septic patients is not able to alter the plasma concentration of cytokines therapeutically.

Authors:  M van Deuren; J W van der Meer
Journal:  Intensive Care Med       Date:  2000-09       Impact factor: 17.440

Review 2.  New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal.

Authors:  S Müller; P Scaffidi; B Degryse; T Bonaldi; L Ronfani; A Agresti; M Beltrame; M E Bianchi
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

3.  Extracellular processing of amphoterin generates a peptide active on erythroleukaemia cell differentiation.

Authors:  B Sparatore; M Patrone; M Passalacqua; M Pedrazzi; D Gaggero; S Pontremoli; E Melloni
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

4.  Hematopoietic stem-progenitor cells restore immunoreactivity and improve survival in late sepsis.

Authors:  Laura Brudecki; Donald A Ferguson; Deling Yin; Gene D Lesage; Charles E McCall; Mohamed El Gazzar
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

5.  High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor.

Authors:  Hulda Sigridur Hreggvidsdóttir; Anna M Lundberg; Ann-Charlotte Aveberger; Lena Klevenvall; Ulf Andersson; Helena Erlandsson Harris
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

6.  2-O, 3-O-desulfated heparin inhibits neutrophil elastase-induced HMGB-1 secretion and airway inflammation.

Authors:  Kathryn L Griffin; Bernard M Fischer; Apparao B Kummarapurugu; Shuo Zheng; Thomas P Kennedy; Narayanam V Rao; W Michael Foster; Judith A Voynow
Journal:  Am J Respir Cell Mol Biol       Date:  2014-04       Impact factor: 6.914

7.  The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway.

Authors:  Stefania Gardella; Cristina Andrei; Denise Ferrera; Lavinia V Lotti; Maria R Torrisi; Marco E Bianchi; Anna Rubartelli
Journal:  EMBO Rep       Date:  2002-09-13       Impact factor: 8.807

8.  Anti-inflammatory effects of hyperoside in human endothelial cells and in mice.

Authors:  Sae-Kwang Ku; Wei Zhou; Wonhwa Lee; Min-Su Han; MinKyun Na; Jong-Sup Bae
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

9.  Orientin inhibits HMGB1-induced inflammatory responses in HUVECs and in murine polymicrobial sepsis.

Authors:  Hayoung Yoo; Sae-Kwang Ku; Taeho Lee; Jong-Sup Bae
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

10.  Chronic sepsis mortality characterized by an individualized inflammatory response.

Authors:  Marcin F Osuchowski; Kathy Welch; Huan Yang; Javed Siddiqui; Daniel G Remick
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.